United States· US:0456-1550_d6462f8d-f32a-4157-bc50-9831da50c453
Savella
A milnacipran product containing milnacipran hydrochloride, registered in United States by Allergan, Inc.. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Milnacipran is registered in 6 of 19 countries.
Countries holding a registration under ATC N06AX17 (milnacipran), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Milnacipran · ATC N06AX17
6 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Japan
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of milnacipran costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- United States: $24.47 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Milnacipran · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- US United States$24.47 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MILNACIPRAN HYDROCHLORIDE
- Manufacturer
- Allergan, Inc.
- Country
- United States (US)
- ATC code
- N06AX17
- ATC class
- Milnacipran
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110456-1550-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
194 interactions on record for milnacipran.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Milnacipran · interactions on record
194 records
- 27 severe
- 167 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Milnacipran in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyMilnacipran GlenmarkGlenmark Arzneimittel Gmbh
- FinlandIxelPierre Fabre Pharma Norden AB
- FranceMILNACIPRAN ARROW 25 mg, géluleARROW GENERIQUES
- United KingdomMilnacipran 50mg capsulesSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Milnacipran Glenmark, Milnacipran Rivopharm
- Germany · Milnacipran Glenmark, Milnacipran Holsten
- France · Milnacipran Arrow, Milnacipran Eg
- Luxembourg · Milnacipran Micro Labs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6a19db4-5bec-4443-91fd-e4beae5cb430 GET /v1/drugs/b6a19db4-5bec-4443-91fd-e4beae5cb430?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "MILNACIPRAN HYDROCHLORIDE",
"productndc": "0456-1550",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA022256",
"marketing_category": "NDA"
}See everything about milnacipran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.